表紙
市場調查報告書
商品編碼
1028026

遠端患者監護 (RPM)的全球市場:各產品 (軟體,服務,連網型設備)、各終端用戶 (醫療提供者,醫院,診療所,居家醫療,患者,到付款者)的預測 (2027年)

Global Remote Patient Monitoring (RPM) Market by Product (Software, Services, Connected Devices) End User (Providers, Hospitals, Clinics, Home Care, Patients, Payers) - Global Forecast to 2027

出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 213 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球遠端患者監護 (RPM)的市場規模,預計自2020年以最大34%的年複合成長率成長,2027年達到1770億美元。市場主要促進因素,是老年人口增加和慢性疾病的患者增加,對醫療獲取的擴大,醫療費和醫療資源的負擔的減輕,投資的擴大等。還有防止感染疾病的擴大上RPM顯示高效用,也提供成長機會。

各類型中,設備部門佔最大的佔有率。還有各地區中,北美各國有壓倒性的佔有率,另一方面亞太地區各國也以高年複合成長率成長。

本報告提供全球遠端患者監護 (RPM)的市場相關分析,市場基本結構和主要的影響要素,整體市場規模趨勢預測,各類型、各終端用戶的市場佔有率結構,各地區的詳細趨勢,主要企業簡介等調查。

目錄

第1章 簡介

第2章 分析方法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題

第5章 產業的考察

  • 簡介
  • 產業趨勢

第6章 全球遠端患者監護市場:各類型 (單位:100萬美元,2019年∼2027年)

  • 服務、軟體
  • 設備

第7章 全球遠端患者監護市場:各終端用戶 (單位:100萬美元,2019年∼2027年)

  • 醫療提供者
  • 付款人
  • 患者
  • 其他終端用戶

第8章 全球遠端患者監護市場:各地區 (單位:100萬美元,2019年∼2027年)

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他的歐洲各國
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他的亞太地區各國
  • 其他的國家 (RoW)
    • 南美
    • 中東、非洲

第9章 競爭情形

  • 簡介
  • 主要企業的市場佔有率分析 (2020年)
  • 競爭情形與趨勢
    • 產品銷售
    • 事業聯盟、合作,契約
    • 企業收購
    • 事業擴張
    • 其他動向

第10章 企業簡介

  • BioTelemetry Inc. (美國)
  • Koninklijke Philips N.V. (荷蘭)
  • Medtronic (Ireland)
  • GE Healthcare (美國)
  • Cerner Corporation (美國)
  • Siemens Healthineers AG (德國)
  • OMRON Healthcare (日本)
  • Boston Scientific Corporation (美國)
  • Abbott Laboratories (美國)
  • Resideo Life Care Solutions (美國)
  • Vivify Health, Inc. (美國)
  • ALTEN Calsoft Labs (France)
  • Preventice Solutions (美國)
  • Bio-Beat Technologies (以色列)
  • VitalConnect (美國)
  • Welch Allyn (美國)
  • Teladoc Health Inc. (美國)
  • Dexcom Inc. (美國)
  • iRhythm Technologies, Inc. (美國)
  • VivaLNK Inc. (美國).

第11章 附錄

目錄
Product Code: HLCA2115

The global remote patient monitoring market is expected to grow at a CAGR of ~34% from 2020 to reach ~177 billion by 2027. The growth is primarily attributed to growing geriatric population with rising prevalence of chronic diseases, demand for expansion of healthcare access, reduction in healthcare costs & burden on medical resources and increasing investments. However, variations in regulatory framework and healthcare frauds are expected to hinder the growth of the market. High utility of remote patient monitoring in containing the contagious diseases provide with growth opportunities.

By Type: Device segment to lead the market in 2020

The global remote patient monitoring market is segmented into software & services, and devices, based on type. The device segment accounted for the largest share in 2020. The large share of this market segment can be attributed to demand surge for remote monitoring devices for tracking vitals in various countries. This high demand of connected devices is further fuelled by COVID-19 outbreak.

By End User: Providers to dominate the remote patient monitoring market

Provider segment accounted for largest share of remote patient monitoring market, by end user in 2020. The large share is mainly attributed to growing adoption of remote patient monitoring in geriatric and chronically ill patients, technological advancements and improving remote monitoring services.

By Region: North America expected to dominate the regional market

North America is expected to dominate the remote patient monitoring market by region. The large share is primarily attributed to rapidly increasing adoption of connected devices and remote patient monitoring services, prevalence of chronic diseases, growing geriatric population and initiatives to curb healthcare expenditure. APAC is expected to register highest CAGR. Increasing awareness on remote patient monitoring services, growing focus on connected devices by patient, and rapidly expanding patient pool are expected to drive the growth of this regional segment.

Competitive Scenario:

  • BioTelemetry Inc. (US)
  • Koninklijke Philips N.V. (Netherlands)
  • Medtronic (Ireland)
  • GE Healthcare (US)
  • Cerner Corporation (US)
  • Siemens Healthineers AG Germany
  • OMRON Healthcare (Japan)
  • Boston Scientific Corporation (US)
  • Abbott Laboratories (US)
  • Resideo Life Care Solutions (US)
  • Vivify Health Inc. (US)
  • ALTEN Calsoft Labs (France)
  • Preventice Solutions (US)
  • Bio-Beat Technologies (Israel)
  • VitalConnect (US)
  • Welch Allyn (US)
  • Teladoc Health Inc. (US)
  • Dexcom Inc. (US)
  • iRhythm Technologies Inc. (US)
  • and VivaLNK Inc. (US)

are some of the key players operating in this market.

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges

5. Industry Insights

  • 5.1. Introduction
  • 5.2. Industry Trends

6. Global Remote Patient Monitoring Market, By Type, 2019-2027 (USD Million)

  • 6.1. Services & software
  • 6.2. Devices

7. Global Remote Patient Monitoring Market, By End User, 2019-2027 (USD Million)

  • 7.1. Providers
  • 7.2. Payers
  • 7.3. Patients
  • 7.4. Other End Users

8. Global Remote Patient Monitoring Market, By Geography, 2019-2027 (USD Million)

  • 8.1. North America
    • 8.1.1. US
    • 8.1.2. Canada
  • 8.2. Europe
    • 8.2.1. Germany
    • 8.2.2. UK
    • 8.2.3. France
    • 8.2.4. Italy
    • 8.2.5. Spain
    • 8.2.6. Rest of Europe
  • 8.3. Asia-Pacific
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. India
    • 8.3.4. Rest of Asia-Pacific
  • 8.4. Rest of the World
    • 8.4.1. Latin America
    • 8.4.2. Middle East & Africa

9. Competitive Landscape

  • 9.1. Introduction
  • 9.2. Market Share Analysis, By Key Players (2020)
  • 9.3. Competitive Situation and Trends
    • 9.3.1. Product Launches
    • 9.3.2. Partnerships, Collaborations and Agreements
    • 9.3.3. Acquisitions
    • 9.3.4. Expansions
    • 9.3.5. Other Developments

10. Company Profiles

  • 10.1. BioTelemetry Inc. (US)
  • 10.2. Koninklijke Philips N.V. (Netherlands)
  • 10.3. Medtronic (Ireland)
  • 10.4. GE Healthcare (US)
  • 10.5. Cerner Corporation (US)
  • 10.6. Siemens Healthineers AG Germany
  • 10.7. OMRON Healthcare (Japan)
  • 10.8. Boston Scientific Corporation (US)
  • 10.9. Abbott Laboratories (US)
  • 10.10. Resideo Life Care Solutions (US)
  • 10.11. Vivify Health, Inc. (US)
  • 10.12. ALTEN Calsoft Labs (France)
  • 10.13. Preventice Solutions (US)
  • 10.14. Bio-Beat Technologies (Israel)
  • 10.15. VitalConnect (US)
  • 10.16. Welch Allyn (US)
  • 10.17. Teladoc Health Inc. (US)
  • 10.18. Dexcom Inc. (US)
  • 10.19. iRhythm Technologies, Inc. (US)
  • 10.20. VivaLNK Inc. (US).

11. Appendix